ICON Plc

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°CNet-Zero: Targets set

SBTI ID

40014831

Informations générales

Localisation

Ireland

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

07/11/2024

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon FY2028

Statut

Targets set

Classification

1.5°C

Année cible

FY2028

Progression vers l'objectif0%
2015 (année de référence)FY2028
Objectifs à long terme (Long-Term)
Engagement de réduction des émissions à horizon FY2050

Statut

Targets set

Classification

1.5°C

Année cible

FY2050

Progression vers l'objectif0%
2015 (année de référence)FY2050
Description complète des objectifs

Overall Net-Zero Target: ICON plc commits to reach net-zero greenhouse gas emissions across the value chain by FY2050. Near-Term Targets: ICON plc commits to reduce absolute scope 1 and 2 GHG emissions 61.2% by FY2028 from a FY2019 base year. ICON plc also commits to reduce absolute scope 3 GHG emissions 20.0% by FY2028 from a FY2022 base year. Long-Term Targets: ICON plc commits to reduce absolute scope 1 and 2 GHG emissions 90.0% by FY2050 from a FY2019 base year. ICON plc also commits to reduce absolute scope 3 GHG emissions 90.0% by FY2050 from a FY2022 base year

Net-Zero

Statut

Targets set

Année cible

FY2050

Progression0%
Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

IE0005711209

Source : Science Based Targets initiative | Données publiques